Amgen Reports Fourth Quarter And Full Year 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Amgen (AMGN) PT Raised to $205 at Bernstein Following 4Q
February 2, 2018 8:06 AM ESTBernstein raised its price target on Amgen (NASDAQ: AMGN) to $205.00 (from $189.00) while maintaining a Market Perform rating following the company's 4Q earnings report. Amgen missed a bit on top line with a bit more of a material miss on EPS ($5,602, -0.7%; $2.89, -14c). The... More
Amgen (AMGN) PT Raised to $224 at Oppenheimer
February 2, 2018 6:54 AM ESTOppenheimer raised its price target on Amgen (NASDAQ: AMGN) to $224.00 (from $205.00) while maintaining an Outperform rating.
Analyst Leah Rush Cann commented, "Amgen reported GAAP earnings per share, before a one-time tax-reform charge, of $2.70, which is 9.2% lower than our estimate of $2.97. Earnings were... More
Amgen (AMGN) Misses Q4 EPS by 14c
February 1, 2018 4:02 PM ESTAmgen (NASDAQ: AMGN) reported Q4 EPS of $2.89, $0.14 worse than the analyst estimate of $3.03. Revenue for the quarter came in at $5.8 billion versus the consensus estimate of $5.83 billion.
GUIDANCE:
Amgen sees FY2018 EPS of $12.60-$13.70, versus the consensus of $12.71.
For the fourth quarter, total revenues decreased 3 percent versus the fourth quarter of 2016 to $5.8... More